Provided by Tiger Trade Technology Pte. Ltd.

Ambrx Biopharma Inc

28.00
0.0000
Volume:- -
Turnover:40.30M
Market Cap:1.77B
PE:-117.80
High:28.00
Open:28.00
Low:28.00
Close:28.00
52wk High:28.15
52wk Low:5.56
Shares:63.35M
Float Shares:20.93M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2377
EPS(LYR):-0.2886
ROE:-37.23%
ROA:-18.62%
PB:7.32
PE(LYR):-97.02

Loading ...

Company Profile

Company Name:
Ambrx Biopharma Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California.